Vaccine Design and Testing – News and Features

An “unconventional” immune response recently identified by scientists is a potential new pathway for developing new vaccines for tuberculosis.

Using a novel imaging technique, researchers have described how a parasite “kisses” the surface of host cells before infection and how this affects host cell metabolism.

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling.

Combining a pathogen's genomic DNA with human travel patterns from anonymized mobile phone data provides a new way to prevent superbug outbreaks.

A series of preclinical trials suggests that researchers could be closer to an immunization regimen for HIV than ever before.

According to research, bird flu in unpasteurized milk is stable on metal and rubber components of commercial milking equipment for at least one hour, increasing its potential to infect people and other animals.

A new study, led by UC San Francisco, has found that COVID vaccine side effects symptoms indicate a robust immune response that is likely to lessen the chances of infection.

Researchers have uncovered important immune signatures in children with infected flares of eczema. Technology Networks spoke to Dr. Rachel McLoughlin to learn how these findings could guide the development of a tailored eczema vaccine.

A new study adds evidence supporting the safety of COVID-19 vaccination during pregnancy, finding that vaccination is not associated with an increased risk of preterm birth.

A scientific team has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.